BACKGROUND: Generalized anxiety disorder (GAD) is prevalent and significantly impacts patient health-related quality of life (HRQL) and disability. PURPOSE: This study evaluated the effect of GAD and anxiety symptom severity on the HRQL of primary-care patients with GAD. METHODS: Patients 18 years or older with GAD were recruited from an integrated health care delivery system. Clinical assessments included the Hamilton Anxiety Rating Scale (HAM-A), GAD Questionnaire-IV (GAD-Q-IV), and the Patient Health Questionnaire depression module (PHQ). HRQL was assessed by the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q-SF), Sheehan Disability Scale (SDS), SF-12 Health Survey (SF-6D), and the Health Utilities Index (HUI2, HUI3). RESULTS: The sample included 297 patients, 72% women with mean +/- standard deviation (SD) age of 47.6 +/- 13.7 years. At baseline, the mean HAM-A score was 16.8 +/- 7.6 (suggesting the presence of moderate anxiety symptoms). Anxiety and depression symptoms were significantly correlated with mental component summary (MCS), Q-LES-Q-SF, SDS, SF-6D, HUI2, and HUI3 scores (all P < 0.001). The mean HRQL and all of the preference-based measures varied significantly by anxiety severity groups (all P < 0.001). Anxiety and depression symptoms significantly predicted HRQL and preference-based scores (R(2) values ranged from 0.22 to 0.57). CONCLUSIONS: Anxiety symptoms reported by GAD patients resulted in significant impairment to HRQL and functional outcomes.
BACKGROUND:Generalized anxiety disorder (GAD) is prevalent and significantly impacts patient health-related quality of life (HRQL) and disability. PURPOSE: This study evaluated the effect of GAD and anxiety symptom severity on the HRQL of primary-care patients with GAD. METHODS:Patients 18 years or older with GAD were recruited from an integrated health care delivery system. Clinical assessments included the Hamilton Anxiety Rating Scale (HAM-A), GAD Questionnaire-IV (GAD-Q-IV), and the Patient Health Questionnaire depression module (PHQ). HRQL was assessed by the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q-SF), Sheehan Disability Scale (SDS), SF-12 Health Survey (SF-6D), and the Health Utilities Index (HUI2, HUI3). RESULTS: The sample included 297 patients, 72% women with mean +/- standard deviation (SD) age of 47.6 +/- 13.7 years. At baseline, the mean HAM-A score was 16.8 +/- 7.6 (suggesting the presence of moderate anxiety symptoms). Anxiety and depression symptoms were significantly correlated with mental component summary (MCS), Q-LES-Q-SF, SDS, SF-6D, HUI2, and HUI3 scores (all P < 0.001). The mean HRQL and all of the preference-based measures varied significantly by anxiety severity groups (all P < 0.001). Anxiety and depression symptoms significantly predicted HRQL and preference-based scores (R(2) values ranged from 0.22 to 0.57). CONCLUSIONS:Anxiety symptoms reported by GAD patients resulted in significant impairment to HRQL and functional outcomes.
Authors: Murray B Stein; Peter P Roy-Byrne; Michelle G Craske; Alexander Bystritsky; Greer Sullivan; Jeffrey M Pyne; Wayne Katon; Cathy D Sherbourne Journal: Med Care Date: 2005-12 Impact factor: 2.983
Authors: Hans-Ulrich Wittchen; Ron C Kessler; Katja Beesdo; Petra Krause; Michael Höfler; Jürgen Hoyer Journal: J Clin Psychiatry Date: 2002 Impact factor: 4.384
Authors: M Ansseau; M Dierick; F Buntinkx; P Cnockaert; J De Smedt; M Van Den Haute; D Vander Mijnsbrugge Journal: J Affect Disord Date: 2004-01 Impact factor: 4.839
Authors: Dennis G Fryback; Nancy Cross Dunham; Mari Palta; Janel Hanmer; Jennifer Buechner; Dasha Cherepanov; Shani A Herrington; Ron D Hays; Robert M Kaplan; Theodore G Ganiats; David Feeny; Paul Kind Journal: Med Care Date: 2007-12 Impact factor: 2.983
Authors: Norah E Mulvaney-Day; Marcela Horvitz-Lennon; Chih-Nan Chen; Mara Laderman; Margarita Alegría Journal: Qual Life Res Date: 2010-08-01 Impact factor: 4.147
Authors: Cathrine Mihalopoulos; Lidia Engel; Long Khanh-Dao Le; Anne Magnus; Meredith Harris; Mary Lou Chatterton Journal: Qual Life Res Date: 2018-04-09 Impact factor: 4.147
Authors: William Furlong; Charlene Rae; David Feeny; Richard D Gelber; Caroline Laverdiere; Bruno Michon; Lewis Silverman; Stephen Sallan; Ronald Barr Journal: Pediatr Blood Cancer Date: 2012-01-31 Impact factor: 3.167
Authors: Mark S Kaplan; Nathalie Huguet; David Feeny; Bentson H McFarland; Raul Caetano; Julie Bernier; Norman Giesbrecht; Lisa Oliver; Nancy Ross Journal: J Stud Alcohol Drugs Date: 2012-07 Impact factor: 2.582